Patents by Inventor Robert MAGIN

Robert MAGIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20260258011
    Abstract: The disclosure relates to compounds that act as inhibitors of VCPIP1 and related DUBs; pharmaceutical compositions comprising the compounds; and methods of treating or preventing DUB-mediated disorders, including cancer and other proliferation diseases.
    Type: Application
    Filed: June 29, 2023
    Publication date: September 3, 2026
    Inventors: Sara Jean Buhrlage, Xiaoxi Liu, Wai Cheung Chan, Robert Magin, Cara Starnbach
  • SMALL MOLECULE INHIBITION OF DEUBIQUITINATING ENZYME JOSEPHIN DOMAIN CONTAINING 1 (JOSD1) AS A TARGETED THERAPY FOR LEUKEMIAS WITH MUTANT JANUS KINASE 2 (JAK2)
    Publication number: 20240335427
    Abstract: Disclosed are deubiquitinase (DUB) JOSD1 inhibitors and methods of treating a disease or disorder mediated by dysregulated Janus Kinase 2 (JAK2) activity, in a subject in need thereof, comprising administering a therapeutically effective amount of one or more DUB inhibitors.
    Type: Application
    Filed: July 25, 2022
    Publication date: October 10, 2024
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Sara BUHRLAGE, James GRIFFIN, Ellen WEISBERG, Jing YANG, Xiaoxi LIU, Robert MAGIN, Bin HU, Wai Cheung CHAN